Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Expert Opinion on Therapeutic Patents|March 23, 2012
Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligandsStephanie Federico, Giampiero SpallutoCurrent Medicinal Chemistry|January 11, 2005
Non peptidic alphavbeta3 antagonists: recent developmentsBarbara Cacciari, Giampiero SpallutoMini Reviews in Medicinal Chemistry|April 26, 2018
A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?Barbara Cacciari, Giampiero Spalluto, Stephanie FedericoCurrent Topics in Medicinal Chemistry|February 7, 2003
Medicinal chemistry of A2A adenosine receptor antagonistsBarbara Cacciari, Giorgia Pastorin, Giampiero SpallutoPharmaceuticals (Basel, Switzerland)|November 16, 2019
Chemical Probes for the Adenosine ReceptorsStephanie Federico, Lucia Lassiani, Giampiero SpallutoTrends in Pharmacological Sciences|January 5, 2005
Techniques: Recent developments in computer-aided engineering of GPCR ligands using the human adenosine A3 receptor as an exampleStefano Moro, Giampiero Spalluto, Kenneth A JacobsonJournal of Medicinal Chemistry|September 2, 2005
Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A(3) adenosine receptor antagonistsStefano Moro, Magdalena Bacilieri, Barbara Cacciari, et al.Current Pharmaceutical Design|June 27, 2006
Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticityStefano Moro, Francesca Deflorian, Magdalena Bacilieri, et al.Current Drug Discovery Technologies|February 14, 2006
Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as alternative attractive tool to generate ligand-based 3D-QSARsStefano Moro, Magdalena Bacilieri, Cristina Ferrari, et al.Methods in Enzymology|November 6, 2010
Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agentsSilvia Paoletta, Stephanie Federico, Giampiero Spalluto, et al.Pageof 9